Quick Answer
Compass Therapeutics, Inc. reported Common Stock Shares Outstanding of 178.32 million shares for the year ending 2025.
- Compass Therapeutics, Inc. showed an increase of +29.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Compass Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2018 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2018 to 2025), Compass Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 3,466.5%.
- Historical annual values: Fiscal year 2025: 178.32 million shares | Fiscal year 2024: 137.82 million shares | Fiscal year 2023: 127.67 million shares | Fiscal year 2022: 126.30 million shares | Fiscal year 2021: 100.83 million shares | Fiscal year 2020: 51.22 million shares | Fiscal year 2020: 5.00 million shares | Fiscal year 2019: 7.03 million shares | Fiscal year 2019: 5.00 million shares | Fiscal year 2018: 5.00 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: